Boston Scientific touts Vercise DBS for Parkinson's

Boston Scientific touts data from a small study of short-pulse deep-brain stimulation with its Vercise device for Parkinson's disease.

Boston Scientific (NYSE:BSX) said a 15-patient study of its Vercise deep-brain stimulation device showed that shorter pulses may be better in treating Parkinson's disease than conventional, wider pulses.

Boston Scientific

News Well, Clinical Trials, Deep-brain stimulation, Parkinson's disease

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qu5cYR